Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions

Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions

US Patent 8753610 · Granted Jun 17, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2024
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2024
Methods and compositions for increasing alpha-L-iduronidase activity in the CNS2022
Methods and compositions for increasing alpha-L-iduronidase activity in the CNS2022
Macromolecular compositions that cross the blood-brain barrier and methods of us2021
Macromolecular compositions that cross the blood-brain barrier and methods of us2021
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2021
Methods and compositions for increasing iduronate 2-sulfatase activity in the CN2021
Compositions and methods related to structures that cross the blood brain barrie2021
Compositions and methods related to structures that cross the blood brain barrie2021
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity2020
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity2020